September 19, 2017 09:12 AM EDT
People

On­coMed chief Paul Hast­ings goes on med­ical leave

John Carroll

Editor & Founder

The long­time biotech ex­ec and On­coMed $OMED CEO Paul Hast­ings is go­ing on med­ical leave.

There’s no im­me­di­ate word about what ails him, but the …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Vice President, Biology & Translational Research

Gondolabio

Palo Alto, CA, USA

TRENDING NOW

Up­dat­ed: Zealand part­ners with Roche on its amylin ana­log in a deal worth up to $5.3B

In­sil­i­co nabs $110M Se­ries E for AI drug dis­cov­ery af­ter stalling Hong Kong IPO plans

#CROI25: Mer­ck’s trou­bled HIV drug heads to reg­u­la­tors; Vi­iV seeks longer-act­ing HIV treat­ment

Ono li­cens­es rare blood dis­ease drug from Io­n­is for $280M up­front

Leg­end to dou­ble Carvyk­ti pro­duc­tion as it tar­gets block­buster sta­tus 

sponsored

Obe­si­ty drug de­vel­op­ment—still room to grow

A service from the Financial Times